BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 52 hits with Last Name = 'szokoli' and Initial = 't'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546431
PNG
(CHEMBL4759005)
Show SMILES C#Cc1ccc-2c(CCCc3nnc(C4CCN(CC4)c4ccccn4)n-23)c1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
0.450n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546437
PNG
(CHEMBL4799412)
Show SMILES Brc1ccc-2c(CCCc3nnc([C@H]4CC[C@@H](CC4)Oc4ccccn4)n-23)c1 |r,wU:13.12,wD:16.19,(39.85,-28.42,;41.2,-29.15,;42.52,-28.33,;43.87,-29.07,;43.91,-30.61,;42.6,-31.41,;42.41,-32.94,;43.49,-34.04,;45.02,-33.88,;45.85,-32.58,;47.38,-32.59,;47.85,-31.13,;46.61,-30.22,;46.6,-28.68,;45.27,-27.9,;45.28,-26.36,;46.62,-25.59,;47.95,-26.37,;47.95,-27.92,;46.63,-24.06,;45.3,-23.28,;45.32,-21.75,;43.99,-20.97,;42.66,-21.74,;42.66,-23.28,;43.98,-24.05,;45.36,-31.13,;41.25,-30.68,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
0.600n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546416
PNG
(CHEMBL4778087)
Show SMILES Cc1ccccc1N1CCN(CC1)C(=O)N1C[C@H](Cc2cc(Cl)ccc12)C(=O)N1CCCC1 |r|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
0.600n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546434
PNG
(CHEMBL4756031)
Show SMILES Cc1cc(no1)[C@H]1CC[C@@H](CC1)c1nnc2CCCc3cc(Br)ccc3-n12 |r,wU:9.13,wD:6.6,(77.36,-1.51,;78.26,-2.75,;77.79,-4.21,;79.02,-5.1,;80.26,-4.21,;79.79,-2.76,;79.02,-6.63,;77.68,-7.4,;77.67,-8.94,;79,-9.72,;80.34,-8.96,;80.35,-7.41,;79.01,-11.26,;80.25,-12.17,;79.77,-13.63,;78.25,-13.62,;77.41,-14.92,;75.88,-15.08,;74.81,-13.98,;74.99,-12.45,;73.64,-11.72,;73.6,-10.19,;72.25,-9.46,;74.92,-9.37,;76.27,-10.11,;76.31,-11.65,;77.76,-12.17,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
0.600n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546439
PNG
(Balovaptan | RG-7314 | RO-5285119 | RO5285119 | Rg...)
Show SMILES CN1Cc2nnc([C@H]3CC[C@@H](CC3)Oc3ccccn3)n2-c2ccc(Cl)cc2C1 |r,wU:7.6,wD:10.13,(-.51,-6.75,;-1.47,-5.54,;-.79,-4.16,;-1.45,-2.76,;-.65,-1.45,;-1.66,-.28,;-3.08,-.88,;-4.39,-.07,;-5.74,-.79,;-7.05,.02,;-7,1.56,;-5.65,2.28,;-4.34,1.47,;-8.31,2.37,;-9.67,1.64,;-9.72,.1,;-11.08,-.63,;-12.38,.19,;-12.34,1.72,;-10.98,2.45,;-2.95,-2.41,;-4.16,-3.37,;-5.49,-2.59,;-6.83,-3.35,;-6.83,-4.89,;-8.17,-5.65,;-5.51,-5.67,;-4.17,-4.91,;-2.97,-5.87,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
Purchase

MCE
PC cid
PC sid
UniChem
Article
PubMed
0.700n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546429
PNG
(CHEMBL4746716)
Show SMILES Brc1ccc-2c(CCCc3nnc(C4CCN(CC4)c4ccccn4)n-23)c1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
0.700n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546433
PNG
(CHEMBL4756737)
Show SMILES Cc1cc(no1)[C@H]1CC[C@@H](CC1)c1nnc2CCCc3cc(Cl)ccc3-n12 |r,wU:9.13,wD:6.6,(60.97,-1.63,;61.87,-2.87,;61.39,-4.32,;62.63,-5.22,;63.87,-4.33,;63.4,-2.87,;62.63,-6.75,;61.28,-7.51,;61.27,-9.05,;62.61,-9.84,;63.95,-9.07,;63.96,-7.52,;62.61,-11.38,;63.86,-12.28,;63.38,-13.74,;61.85,-13.74,;61.02,-15.04,;59.49,-15.2,;58.42,-14.1,;58.6,-12.57,;57.25,-11.84,;57.21,-10.3,;55.85,-9.57,;58.52,-9.49,;59.88,-10.23,;59.92,-11.76,;61.36,-12.28,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
0.700n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546436
PNG
(CHEMBL4799793)
Show SMILES Clc1ccc-2c(CCCc3nnc([C@H]4CC[C@@H](CC4)Oc4ccccn4)n-23)c1 |r,wU:13.12,wD:16.19,(20.56,-28.4,;21.91,-29.12,;23.23,-28.31,;24.58,-29.05,;24.62,-30.59,;23.31,-31.39,;23.13,-32.92,;24.2,-34.02,;25.73,-33.86,;26.56,-32.56,;28.09,-32.56,;28.56,-31.1,;27.32,-30.2,;27.31,-28.66,;25.98,-27.88,;25.99,-26.34,;27.34,-25.57,;28.67,-26.35,;28.66,-27.9,;27.34,-24.04,;26.01,-23.27,;26.02,-21.74,;24.69,-20.97,;23.36,-21.74,;23.36,-23.28,;24.69,-24.04,;26.07,-31.1,;21.96,-30.66,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
0.800n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546428
PNG
(CHEMBL4778839)
Show SMILES Clc1ccc-2c(CCCc3nnc(C4CCN(CC4)c4ccccn4)n-23)c1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
1.40n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546417
PNG
(CHEMBL4751140)
Show SMILES Clc1ccc2N(CCNc2c1)C(=O)C1CCN(CC1)c1ccccn1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
1.40n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546435
PNG
(CHEMBL4786172)
Show SMILES Cc1cc(no1)[C@H]1CC[C@@H](CC1)c1nnc2CCCc3ccccc3-n12 |r,wU:9.13,wD:6.6,(7.34,-20.86,;8.24,-22.11,;7.76,-23.56,;9,-24.46,;10.24,-23.57,;9.77,-22.11,;9,-25.99,;7.66,-26.75,;7.65,-28.29,;8.98,-29.07,;10.32,-28.31,;10.33,-26.76,;8.99,-30.62,;10.23,-31.52,;9.75,-32.98,;8.22,-32.97,;7.39,-34.27,;5.86,-34.44,;4.79,-33.33,;4.97,-31.8,;3.62,-31.07,;3.58,-29.54,;4.9,-28.73,;6.25,-29.46,;6.29,-31,;7.74,-31.52,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
1.60n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546438
PNG
(CHEMBL4741178)
Show SMILES C1C[C@@H](CC[C@H]1Oc1ccccn1)c1nnc2CCCc3ccccc3-n12 |r,wU:2.14,wD:5.6,(62.24,-26.43,;62.23,-27.97,;63.56,-28.75,;64.91,-27.99,;64.91,-26.44,;63.58,-25.66,;63.59,-24.13,;62.26,-23.35,;62.28,-21.82,;60.95,-21.04,;59.62,-21.8,;59.62,-23.35,;60.94,-24.12,;63.57,-30.29,;64.81,-31.19,;64.33,-32.65,;62.81,-32.65,;61.97,-33.95,;60.45,-34.11,;59.37,-33.01,;59.56,-31.48,;58.21,-30.75,;58.16,-29.21,;59.48,-28.4,;60.83,-29.14,;60.87,-30.68,;62.32,-31.19,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
2.30n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546427
PNG
(CHEMBL4782340)
Show SMILES Clc1ccc-2c(CCc3nnc([C@H]4CC[C@@H](CC4)Oc4ccccn4)n-23)c1 |r,wU:12.11,wD:15.18,(41.04,-52.06,;42.55,-52.36,;43.57,-51.21,;45.07,-51.52,;45.55,-52.97,;44.54,-54.12,;45.01,-55.57,;46.52,-55.89,;47.55,-54.74,;49.09,-54.74,;49.56,-53.28,;48.31,-52.37,;48.31,-50.82,;46.97,-50.04,;46.98,-48.49,;48.33,-47.72,;49.66,-48.5,;49.66,-50.06,;48.34,-46.19,;47.01,-45.42,;47.02,-43.88,;45.7,-43.11,;44.37,-43.87,;44.37,-45.41,;45.69,-46.18,;47.06,-53.28,;43.04,-53.81,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
9n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546426
PNG
(CHEMBL4745524)
Show SMILES Cc1cc(no1)[C@H]1CC[C@@H](CC1)c1nnc2CCc3cc(Cl)ccc3-n12 |r,wU:9.13,wD:6.6,(28.76,-42.13,;29.65,-43.38,;29.17,-44.83,;30.41,-45.74,;31.65,-44.84,;31.19,-43.38,;30.41,-47.28,;29.06,-48.05,;29.04,-49.6,;30.39,-50.38,;31.73,-49.62,;31.74,-48.06,;30.39,-51.93,;31.64,-52.84,;31.16,-54.3,;29.62,-54.3,;28.6,-55.45,;27.09,-55.14,;26.62,-53.68,;25.12,-53.37,;24.63,-51.92,;23.11,-51.62,;25.65,-50.77,;27.15,-51.08,;27.63,-52.53,;29.14,-52.84,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
13n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546432
PNG
(CHEMBL4797387)
Show SMILES CCc1ccc-2c(CCCc3nnc(C4CCN(CC4)c4ccccn4)n-23)c1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
15n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546430
PNG
(CHEMBL4764976)
Show SMILES C1CN(CCC1c1nnc2CCCc3ccccc3-n12)c1ccccn1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
15n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546425
PNG
(CHEMBL4756354)
Show SMILES COC(=O)CC1Cc2cc(Cl)ccc2-n2c1nnc2[C@H]1CC[C@@H](CC1)Oc1ccccn1 |r,wU:19.21,wD:22.28,(48.77,-17.94,;47.27,-17.63,;46.78,-16.17,;47.8,-15.01,;45.28,-15.86,;44.79,-14.39,;43.28,-14.08,;42.81,-12.62,;41.31,-12.31,;40.82,-10.87,;39.31,-10.56,;41.84,-9.71,;43.34,-10.02,;43.83,-11.47,;45.33,-11.78,;45.81,-13.24,;47.35,-13.24,;47.82,-11.78,;46.58,-10.88,;46.57,-9.33,;45.24,-8.54,;45.25,-7,;46.59,-6.24,;47.93,-7.01,;47.92,-8.56,;46.6,-4.7,;45.27,-3.92,;45.29,-2.38,;43.96,-1.6,;42.62,-2.36,;42.62,-3.91,;43.95,-4.68,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
28n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546424
PNG
(CHEMBL4743652)
Show SMILES [H][C@@]12C[C@]1([H])c1cc(Cl)ccc1-n1c(nnc21)[C@H]1CC[C@@H](CC1)c1cc(C)on1 |r,wU:17.20,1.0,3.4,wD:20.27,(82.47,-56.53,;81.71,-55.2,;80.69,-56.35,;80.21,-54.89,;79.11,-55.97,;79.73,-53.43,;78.24,-53.13,;77.74,-51.68,;76.23,-51.37,;78.77,-50.52,;80.27,-50.83,;80.75,-52.28,;82.25,-52.59,;83.5,-51.69,;84.75,-52.59,;84.28,-54.05,;82.74,-54.05,;83.51,-50.15,;82.17,-49.38,;82.18,-47.84,;83.52,-47.07,;84.85,-47.85,;84.84,-49.38,;83.52,-45.53,;82.28,-44.62,;82.77,-43.15,;81.87,-41.9,;84.31,-43.16,;84.77,-44.63,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
55n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546423
PNG
(CHEMBL4778700)
Show SMILES Clc1ccc-2c(CCc3nnc(C4CCN(CC4)c4ccccn4)n-23)c1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
71n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546419
PNG
(CHEMBL4790066)
Show SMILES Cc1cc(no1)[C@H]1CC[C@@H](CC1)c1nnc2C3CC3c3cc(Cl)ccc3-n12 |r,wU:9.13,wD:6.6,(47.62,-42.58,;48.52,-43.82,;48.03,-45.28,;49.28,-46.19,;50.52,-45.29,;50.05,-43.83,;49.27,-47.73,;47.92,-48.5,;47.91,-50.04,;49.25,-50.82,;50.6,-50.06,;50.61,-48.51,;49.26,-52.38,;50.5,-53.28,;50.03,-54.75,;48.49,-54.75,;47.46,-55.9,;46.44,-57.05,;45.95,-55.59,;45.48,-54.12,;43.99,-53.81,;43.49,-52.36,;41.98,-52.06,;44.51,-51.21,;46.02,-51.52,;46.5,-52.97,;48,-53.28,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
100n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546421
PNG
(CHEMBL4748895)
Show SMILES Clc1ccc-2c(c1)C1CC1c1nnc([C@@H]3CC[C@@H](CC3)Oc3ccccn3)n-21 |r,wD:14.15,17.22,(5.97,-51.08,;7.48,-51.38,;8.5,-50.23,;10,-50.54,;10.48,-51.99,;9.46,-53.14,;7.97,-52.83,;9.94,-54.6,;10.42,-56.06,;11.45,-54.91,;12.47,-53.76,;14.01,-53.76,;14.49,-52.3,;13.24,-51.4,;13.23,-49.85,;11.9,-49.06,;11.91,-47.52,;13.26,-46.75,;14.59,-47.53,;14.58,-49.08,;13.26,-45.21,;11.93,-44.43,;11.95,-42.89,;10.62,-42.11,;9.28,-42.88,;9.27,-44.42,;10.6,-45.19,;11.99,-52.3,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
180n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546422
PNG
(CHEMBL4755383)
Show SMILES Clc1ccc-2c(c1)C1CC1c1nnc(C3CCN(CC3)c3ccccn3)n-21
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
260n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546420
PNG
(CHEMBL4786739)
Show SMILES COC(=O)C12CC1c1cc(Cl)ccc1-n1c(nnc21)[C@H]1CC[C@@H](CC1)Oc1ccccn1 |r,wU:19.22,wD:22.29,(31.34,-57.96,;30.58,-56.62,;31.35,-55.29,;32.89,-55.3,;30.59,-53.96,;29.56,-55.11,;29.08,-53.65,;28.6,-52.18,;27.11,-51.88,;26.62,-50.43,;25.11,-50.13,;27.64,-49.28,;29.14,-49.59,;29.62,-51.04,;31.13,-51.35,;32.38,-50.45,;33.63,-51.35,;33.15,-52.81,;31.61,-52.81,;32.37,-48.89,;31.04,-48.11,;31.05,-46.56,;32.4,-45.8,;33.73,-46.57,;33.72,-48.13,;32.4,-44.26,;31.07,-43.48,;31.09,-41.94,;29.76,-41.16,;28.42,-41.92,;28.41,-43.47,;29.74,-44.24,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
400n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V2 receptor


(Homo sapiens (Human))
BDBM50546436
PNG
(CHEMBL4799793)
Show SMILES Clc1ccc-2c(CCCc3nnc([C@H]4CC[C@@H](CC4)Oc4ccccn4)n-23)c1 |r,wU:13.12,wD:16.19,(20.56,-28.4,;21.91,-29.12,;23.23,-28.31,;24.58,-29.05,;24.62,-30.59,;23.31,-31.39,;23.13,-32.92,;24.2,-34.02,;25.73,-33.86,;26.56,-32.56,;28.09,-32.56,;28.56,-31.1,;27.32,-30.2,;27.31,-28.66,;25.98,-27.88,;25.99,-26.34,;27.34,-25.57,;28.67,-26.35,;28.66,-27.9,;27.34,-24.04,;26.01,-23.27,;26.02,-21.74,;24.69,-20.97,;23.36,-21.74,;23.36,-23.28,;24.69,-24.04,;26.07,-31.1,;21.96,-30.66,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
560n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V2a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546418
PNG
(CHEMBL4745630)
Show SMILES [H][C@]12C[C@@]1([H])c1cc(Cl)ccc1-n1c(nnc21)[C@H]1CC[C@@H](CC1)c1cc(C)on1 |r,wU:17.20,wD:20.27,3.4,1.0,(66.07,-56.69,;65.31,-55.37,;64.29,-56.52,;63.81,-55.06,;62.71,-56.13,;63.33,-53.59,;61.84,-53.29,;61.34,-51.84,;59.83,-51.53,;62.36,-50.69,;63.87,-50.99,;64.35,-52.44,;65.85,-52.75,;67.1,-51.85,;68.35,-52.75,;67.88,-54.22,;66.34,-54.22,;67.1,-50.32,;65.77,-49.54,;65.78,-48,;67.12,-47.24,;68.45,-48.01,;68.44,-49.55,;67.12,-45.69,;65.88,-44.78,;66.37,-43.32,;65.46,-42.06,;67.91,-43.32,;68.37,-44.79,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
570n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546414
PNG
(CHEMBL4776887)
Show SMILES COc1nc2cc(Cl)ccc2n2c(nnc12)C1CCN(CC1)c1ccccn1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
700n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546413
PNG
(CHEMBL4780533)
Show SMILES CC1(C)Nc2cc(Cl)ccc2-n2c(nnc12)C1CCN(CC1)c1ccccn1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
800n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546412
PNG
(CHEMBL4762451)
Show SMILES CC(=O)N1c2cc(Cl)ccc2-n2c(nnc2C1(C)C)C1CCN(CC1)c1ccccn1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
2.40E+3n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546415
PNG
(CHEMBL4795303)
Show SMILES Clc1ccc2c(c1)nc1[nH]nc(C3CCN(CC3)c3ccccn3)n21
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
5.20E+3n/an/an/an/an/an/an/an/a


TBA

Assay Description
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546436
PNG
(CHEMBL4799793)
Show SMILES Clc1ccc-2c(CCCc3nnc([C@H]4CC[C@@H](CC4)Oc4ccccn4)n-23)c1 |r,wU:13.12,wD:16.19,(20.56,-28.4,;21.91,-29.12,;23.23,-28.31,;24.58,-29.05,;24.62,-30.59,;23.31,-31.39,;23.13,-32.92,;24.2,-34.02,;25.73,-33.86,;26.56,-32.56,;28.09,-32.56,;28.56,-31.1,;27.32,-30.2,;27.31,-28.66,;25.98,-27.88,;25.99,-26.34,;27.34,-25.57,;28.67,-26.35,;28.66,-27.9,;27.34,-24.04,;26.01,-23.27,;26.02,-21.74,;24.69,-20.97,;23.36,-21.74,;23.36,-23.28,;24.69,-24.04,;26.07,-31.1,;21.96,-30.66,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 1n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric cal...


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546437
PNG
(CHEMBL4799412)
Show SMILES Brc1ccc-2c(CCCc3nnc([C@H]4CC[C@@H](CC4)Oc4ccccn4)n-23)c1 |r,wU:13.12,wD:16.19,(39.85,-28.42,;41.2,-29.15,;42.52,-28.33,;43.87,-29.07,;43.91,-30.61,;42.6,-31.41,;42.41,-32.94,;43.49,-34.04,;45.02,-33.88,;45.85,-32.58,;47.38,-32.59,;47.85,-31.13,;46.61,-30.22,;46.6,-28.68,;45.27,-27.9,;45.28,-26.36,;46.62,-25.59,;47.95,-26.37,;47.95,-27.92,;46.63,-24.06,;45.3,-23.28,;45.32,-21.75,;43.99,-20.97,;42.66,-21.74,;42.66,-23.28,;43.98,-24.05,;45.36,-31.13,;41.25,-30.68,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 1.30n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric cal...


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546434
PNG
(CHEMBL4756031)
Show SMILES Cc1cc(no1)[C@H]1CC[C@@H](CC1)c1nnc2CCCc3cc(Br)ccc3-n12 |r,wU:9.13,wD:6.6,(77.36,-1.51,;78.26,-2.75,;77.79,-4.21,;79.02,-5.1,;80.26,-4.21,;79.79,-2.76,;79.02,-6.63,;77.68,-7.4,;77.67,-8.94,;79,-9.72,;80.34,-8.96,;80.35,-7.41,;79.01,-11.26,;80.25,-12.17,;79.77,-13.63,;78.25,-13.62,;77.41,-14.92,;75.88,-15.08,;74.81,-13.98,;74.99,-12.45,;73.64,-11.72,;73.6,-10.19,;72.25,-9.46,;74.92,-9.37,;76.27,-10.11,;76.31,-11.65,;77.76,-12.17,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 1.70n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric cal...


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546433
PNG
(CHEMBL4756737)
Show SMILES Cc1cc(no1)[C@H]1CC[C@@H](CC1)c1nnc2CCCc3cc(Cl)ccc3-n12 |r,wU:9.13,wD:6.6,(60.97,-1.63,;61.87,-2.87,;61.39,-4.32,;62.63,-5.22,;63.87,-4.33,;63.4,-2.87,;62.63,-6.75,;61.28,-7.51,;61.27,-9.05,;62.61,-9.84,;63.95,-9.07,;63.96,-7.52,;62.61,-11.38,;63.86,-12.28,;63.38,-13.74,;61.85,-13.74,;61.02,-15.04,;59.49,-15.2,;58.42,-14.1,;58.6,-12.57,;57.25,-11.84,;57.21,-10.3,;55.85,-9.57,;58.52,-9.49,;59.88,-10.23,;59.92,-11.76,;61.36,-12.28,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 2.20n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric cal...


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546416
PNG
(CHEMBL4778087)
Show SMILES Cc1ccccc1N1CCN(CC1)C(=O)N1C[C@H](Cc2cc(Cl)ccc12)C(=O)N1CCCC1 |r|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 2.40n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric cal...


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546431
PNG
(CHEMBL4759005)
Show SMILES C#Cc1ccc-2c(CCCc3nnc(C4CCN(CC4)c4ccccn4)n-23)c1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 2.70n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric cal...


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546439
PNG
(Balovaptan | RG-7314 | RO-5285119 | RO5285119 | Rg...)
Show SMILES CN1Cc2nnc([C@H]3CC[C@@H](CC3)Oc3ccccn3)n2-c2ccc(Cl)cc2C1 |r,wU:7.6,wD:10.13,(-.51,-6.75,;-1.47,-5.54,;-.79,-4.16,;-1.45,-2.76,;-.65,-1.45,;-1.66,-.28,;-3.08,-.88,;-4.39,-.07,;-5.74,-.79,;-7.05,.02,;-7,1.56,;-5.65,2.28,;-4.34,1.47,;-8.31,2.37,;-9.67,1.64,;-9.72,.1,;-11.08,-.63,;-12.38,.19,;-12.34,1.72,;-10.98,2.45,;-2.95,-2.41,;-4.16,-3.37,;-5.49,-2.59,;-6.83,-3.35,;-6.83,-4.89,;-8.17,-5.65,;-5.51,-5.67,;-4.17,-4.91,;-2.97,-5.87,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
Purchase

MCE
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 3n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric cal...


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546428
PNG
(CHEMBL4778839)
Show SMILES Clc1ccc-2c(CCCc3nnc(C4CCN(CC4)c4ccccn4)n-23)c1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 3.20n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric cal...


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546429
PNG
(CHEMBL4746716)
Show SMILES Brc1ccc-2c(CCCc3nnc(C4CCN(CC4)c4ccccn4)n-23)c1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 13n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric cal...


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546438
PNG
(CHEMBL4741178)
Show SMILES C1C[C@@H](CC[C@H]1Oc1ccccn1)c1nnc2CCCc3ccccc3-n12 |r,wU:2.14,wD:5.6,(62.24,-26.43,;62.23,-27.97,;63.56,-28.75,;64.91,-27.99,;64.91,-26.44,;63.58,-25.66,;63.59,-24.13,;62.26,-23.35,;62.28,-21.82,;60.95,-21.04,;59.62,-21.8,;59.62,-23.35,;60.94,-24.12,;63.57,-30.29,;64.81,-31.19,;64.33,-32.65,;62.81,-32.65,;61.97,-33.95,;60.45,-34.11,;59.37,-33.01,;59.56,-31.48,;58.21,-30.75,;58.16,-29.21,;59.48,-28.4,;60.83,-29.14,;60.87,-30.68,;62.32,-31.19,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 20n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric cal...


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546435
PNG
(CHEMBL4786172)
Show SMILES Cc1cc(no1)[C@H]1CC[C@@H](CC1)c1nnc2CCCc3ccccc3-n12 |r,wU:9.13,wD:6.6,(7.34,-20.86,;8.24,-22.11,;7.76,-23.56,;9,-24.46,;10.24,-23.57,;9.77,-22.11,;9,-25.99,;7.66,-26.75,;7.65,-28.29,;8.98,-29.07,;10.32,-28.31,;10.33,-26.76,;8.99,-30.62,;10.23,-31.52,;9.75,-32.98,;8.22,-32.97,;7.39,-34.27,;5.86,-34.44,;4.79,-33.33,;4.97,-31.8,;3.62,-31.07,;3.58,-29.54,;4.9,-28.73,;6.25,-29.46,;6.29,-31,;7.74,-31.52,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 25n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric cal...


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546427
PNG
(CHEMBL4782340)
Show SMILES Clc1ccc-2c(CCc3nnc([C@H]4CC[C@@H](CC4)Oc4ccccn4)n-23)c1 |r,wU:12.11,wD:15.18,(41.04,-52.06,;42.55,-52.36,;43.57,-51.21,;45.07,-51.52,;45.55,-52.97,;44.54,-54.12,;45.01,-55.57,;46.52,-55.89,;47.55,-54.74,;49.09,-54.74,;49.56,-53.28,;48.31,-52.37,;48.31,-50.82,;46.97,-50.04,;46.98,-48.49,;48.33,-47.72,;49.66,-48.5,;49.66,-50.06,;48.34,-46.19,;47.01,-45.42,;47.02,-43.88,;45.7,-43.11,;44.37,-43.87,;44.37,-45.41,;45.69,-46.18,;47.06,-53.28,;43.04,-53.81,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 70n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric cal...


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546426
PNG
(CHEMBL4745524)
Show SMILES Cc1cc(no1)[C@H]1CC[C@@H](CC1)c1nnc2CCc3cc(Cl)ccc3-n12 |r,wU:9.13,wD:6.6,(28.76,-42.13,;29.65,-43.38,;29.17,-44.83,;30.41,-45.74,;31.65,-44.84,;31.19,-43.38,;30.41,-47.28,;29.06,-48.05,;29.04,-49.6,;30.39,-50.38,;31.73,-49.62,;31.74,-48.06,;30.39,-51.93,;31.64,-52.84,;31.16,-54.3,;29.62,-54.3,;28.6,-55.45,;27.09,-55.14,;26.62,-53.68,;25.12,-53.37,;24.63,-51.92,;23.11,-51.62,;25.65,-50.77,;27.15,-51.08,;27.63,-52.53,;29.14,-52.84,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 100n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric cal...


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546430
PNG
(CHEMBL4764976)
Show SMILES C1CN(CCC1c1nnc2CCCc3ccccc3-n12)c1ccccn1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 117n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric cal...


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546425
PNG
(CHEMBL4756354)
Show SMILES COC(=O)CC1Cc2cc(Cl)ccc2-n2c1nnc2[C@H]1CC[C@@H](CC1)Oc1ccccn1 |r,wU:19.21,wD:22.28,(48.77,-17.94,;47.27,-17.63,;46.78,-16.17,;47.8,-15.01,;45.28,-15.86,;44.79,-14.39,;43.28,-14.08,;42.81,-12.62,;41.31,-12.31,;40.82,-10.87,;39.31,-10.56,;41.84,-9.71,;43.34,-10.02,;43.83,-11.47,;45.33,-11.78,;45.81,-13.24,;47.35,-13.24,;47.82,-11.78,;46.58,-10.88,;46.57,-9.33,;45.24,-8.54,;45.25,-7,;46.59,-6.24,;47.93,-7.01,;47.92,-8.56,;46.6,-4.7,;45.27,-3.92,;45.29,-2.38,;43.96,-1.6,;42.62,-2.36,;42.62,-3.91,;43.95,-4.68,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 220n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric cal...


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546432
PNG
(CHEMBL4797387)
Show SMILES CCc1ccc-2c(CCCc3nnc(C4CCN(CC4)c4ccccn4)n-23)c1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 252n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric cal...


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546417
PNG
(CHEMBL4751140)
Show SMILES Clc1ccc2N(CCNc2c1)C(=O)C1CCN(CC1)c1ccccn1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 260n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric cal...


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546419
PNG
(CHEMBL4790066)
Show SMILES Cc1cc(no1)[C@H]1CC[C@@H](CC1)c1nnc2C3CC3c3cc(Cl)ccc3-n12 |r,wU:9.13,wD:6.6,(47.62,-42.58,;48.52,-43.82,;48.03,-45.28,;49.28,-46.19,;50.52,-45.29,;50.05,-43.83,;49.27,-47.73,;47.92,-48.5,;47.91,-50.04,;49.25,-50.82,;50.6,-50.06,;50.61,-48.51,;49.26,-52.38,;50.5,-53.28,;50.03,-54.75,;48.49,-54.75,;47.46,-55.9,;46.44,-57.05,;45.95,-55.59,;45.48,-54.12,;43.99,-53.81,;43.49,-52.36,;41.98,-52.06,;44.51,-51.21,;46.02,-51.52,;46.5,-52.97,;48,-53.28,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 500n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric cal...


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546424
PNG
(CHEMBL4743652)
Show SMILES [H][C@@]12C[C@]1([H])c1cc(Cl)ccc1-n1c(nnc21)[C@H]1CC[C@@H](CC1)c1cc(C)on1 |r,wU:17.20,1.0,3.4,wD:20.27,(82.47,-56.53,;81.71,-55.2,;80.69,-56.35,;80.21,-54.89,;79.11,-55.97,;79.73,-53.43,;78.24,-53.13,;77.74,-51.68,;76.23,-51.37,;78.77,-50.52,;80.27,-50.83,;80.75,-52.28,;82.25,-52.59,;83.5,-51.69,;84.75,-52.59,;84.28,-54.05,;82.74,-54.05,;83.51,-50.15,;82.17,-49.38,;82.18,-47.84,;83.52,-47.07,;84.85,-47.85,;84.84,-49.38,;83.52,-45.53,;82.28,-44.62,;82.77,-43.15,;81.87,-41.9,;84.31,-43.16,;84.77,-44.63,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 635n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric cal...


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Vasopressin V1a receptor


(Homo sapiens (Human))
BDBM50546423
PNG
(CHEMBL4778700)
Show SMILES Clc1ccc-2c(CCc3nnc(C4CCN(CC4)c4ccccn4)n-23)c1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 1.40E+3n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric cal...


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Potassium voltage-gated channel subfamily H member 2


(Homo sapiens (Human))
BDBM50546427
PNG
(CHEMBL4782340)
Show SMILES Clc1ccc-2c(CCc3nnc([C@H]4CC[C@@H](CC4)Oc4ccccn4)n-23)c1 |r,wU:12.11,wD:15.18,(41.04,-52.06,;42.55,-52.36,;43.57,-51.21,;45.07,-51.52,;45.55,-52.97,;44.54,-54.12,;45.01,-55.57,;46.52,-55.89,;47.55,-54.74,;49.09,-54.74,;49.56,-53.28,;48.31,-52.37,;48.31,-50.82,;46.97,-50.04,;46.98,-48.49,;48.33,-47.72,;49.66,-48.5,;49.66,-50.06,;48.34,-46.19,;47.01,-45.42,;47.02,-43.88,;45.7,-43.11,;44.37,-43.87,;44.37,-45.41,;45.69,-46.18,;47.06,-53.28,;43.04,-53.81,)|
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 7.20E+3n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human ERG by QPatch HTX automated patch clamp system


Citation and Details

Article DOI: 10.1016/j.bmcl.2020.127417
BindingDB Entry DOI: 10.7270/Q2542S52
More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 52 total )  |  Next  |  Last  >>
Jump to: